New numbing shot could ease brain surgery recovery
NCT ID NCT07344181
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a single injection of liposomal bupivacaine, a long-acting numbing drug, can provide better pain relief after brain surgery than the standard numbing drug. About 118 adults having elective brain surgery will be randomly assigned to receive either the new drug or the standard one. Researchers will measure pain levels, opioid use, and patient satisfaction for up to 72 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
liposomal bupivacaine
What this could lead to
If it works, this could provide longer-lasting pain relief after brain surgery, reducing the need for opioids and improving recovery.
What could go wrong
This is a small, early-stage trial (118 people) comparing two numbing drugs, so results may not apply to all patients. The new drug may not work better or could have unexpected side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE CARE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, 100071, China